| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6802179 | Journal of Substance Abuse Treatment | 2016 | 6 Pages |
Abstract
Liver enzymes and TB are rarely elevated in HIV-infected and uninfected patients receiving BUP. Risk of hepatotoxicity was greater in individuals infected with HIV, HCV, or HIV/HCV co-infection, who may benefit from increased monitoring.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Jeanette M. M.D., Janet P. Ph.D., E. Jennifer Edelman, Adam J. M.D., M.P.H., Vincent Lo M.D., Joseph K. M.D., David M.D., Joseph Ph.D., Stephen Ph.D., Julie R. Ph.D., M.P.H., R.N., Cynthia L. M.D., Maria C. M.D., Lynn E. M.D., Kendall Ph.D., Amy C. M.D.,